VFC

Back-to-school and respiratory disease season are just around the corner Protect patients against vaccine-preventable diseases by ordering free, educational print materials for your office! These materials can facilitate timely conversations about immunizations before the school year and respiratory disease season begin. Click the green button below or...

2026-2027 VFC & VFAAR influenza products will be available to ordersoon. Make sure your office is ready! Complete a return in PhilaVax for any 2025-2026 influenza that you stillhave on hand. A guide with step-by-step instructions is available here. Ensure your EHR/EMR is set up to report this...

Nirsevimab-alip (Beyfortus) and clesrovimab-cfor (Enflonsia) ordering is now open for the 2026-2027 season. Beyfortus and Enflonsia are monoclonal antibody immunizations used to prevent RSV infection in infants and young children that can be administered beginning on October 1, 2026. Order a 4-6-week supply now to ensure...

All VFC & VFAAR influenza vaccine supplied by the Philadelphia Immunization Program during the 2025-2026 influenza season has expired. Please account for unused VFC & VFAAR influenza vaccine using PhilaVax:  Complete a return for any remaining influenza doses using PhilaVax. A guide with step-by-step instructions  is available here. Return your vaccine...

Have you enrolled in the Pennsylvania Children’s Access to Routine and Essential Shots (PA CARES) program yet? If you have, no further action is needed. If not, please read on for enrollment instructions. Note that these instructions have been modified since we sent out our previous...

Good news! We're simplifying how temperature data is reported. Beginning Monday, July 13, 2026, vaccine coordinators using PDPH-issued digital data loggers (DDLs) will now submit routine temperature data through PhilaVax only. Click the button below to view the updated temperature reporting guide. View the updated guide!...

The Philadelphia Vaccines for Children (VFC) and the Vaccines for Adults at Risk (VFAAR) annual re-enrollment period is now open! To continue participating, all clinics must submit required forms by June 1, 2026. Clinics enrolled in both programs must complete separate re-enrollments for each program. Complete re-enrollment in 3...

National Infant Immunization Week highlights the importance of protecting children two years and younger from vaccine-preventable diseases. Research consistently shows that healthcare professionals are the most trusted source of vaccine information for parents. We encourage you to use this opportunity to emphasize the importance of timely...

Based on decreased RSV test positivity and pediatric hospitalizations, the Philadelphia Department of Public Health recommends stopping RSV monoclonal antibody immunization (i.e., nirsevimab and clesrovimab) to all eligible patients on April 15, 2026. Administration may continue until April 30, 2026, based on clinical judgment. Due to...

Join us for a training on pediatric immunization techniques on Friday, May 8, 2026! The Immunization Program is hosting a free training on pediatric immunization techniques for practitioners who administer or will administer Vaccines for Children (VFC) immunizations to pediatric patients. We encourage attendance by RNs,...

Adolescent Immunization Action Week (AIAW) reminds us to keep adolescents up-to-date on immunizations that protect against potentially life-threatening diseases like meningitis, tetanus, diphtheria, pertussis, HPV-related cancers, COVID-19, and influenza. Unity® Consortium offers digital and print resources that you can access online, share, or print. See below: Webinar:...

Re-Enrollment Opens May 1, 2026 The Philadelphia Vaccines for Children (VFC) and the Vaccines for Adults at Risk (VFAAR) annual re-enrollment period will take place May 1 - 31, 2026 using PhilaVax. Complete the steps below to prepare for re-enrollment.  Prepare for Re-Enrollment Make sure all required staff have...

PhilaVax will be temporarily closed to new orders from Monday, March 30, 2026 through Wednesday, April 1, 2026 while immunization prices are updated for 2026. Any orders entered into PhilaVax IIS during this time will be deleted from the system and not processed. If you need to...

Increased disease activity indicates season extension The Philadelphia Department of Public Health recommends offering RSV monoclonal antibody immunization (i.e., nirsevimab and clesrovimab) to all eligible patients until April 15, 2026 due to continued RSV hospitalizations.  Federally purchased RSV immunization will no longer be available to order after...

Nationally, COVID-19 activity is increasing from low levels. Continuing to vaccinate is important in protecting vulnerable individuals, such as infants, against the disease. Infants and children between 6 months and 23 months of age are at high risk of severe COVID-19. Children with certain medical conditions, such as asthma and congenital...

There are no changes in vaccine recommendations and availability in Philadelphia.  On Monday, January 5, 2026, the Centers for Disease Control and Prevention (CDC) updated the pediatric immunization schedule, changing several routine childhood vaccines from a routine recommended category to a shared-decision-making and/or high-risk category. Despite these...

RSV activity is elevated in many areas of the country, including Pennsylvania and Philadelphia. RSV (respiratory syncytial virus) immunization remains the most effective protection against RSV illness. A recent study showed that nirsevimab was 81% effective against RSV-associated hospitalization among infants younger than 6 months. Refer to these previous messages regarding availability and...

Prepare for Winter: Protect Your Patients and Your Vaccine Supply Take steps now to keep your vaccine supply safe and your clinic running smoothly through the winter months. Power Outages Review and update your Vaccine Management Plan to ensure all staff know what to do if there’s a power outage...